Bectas Therapeutics
Bectas Therapeutics is a startup headquartered in Houston, United States, founded in 2022. It has raised at least $5.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory. Last updated .
Funding
Bectas Therapeutics has raised at least $5.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Bectas Therapeutics sits inside the Houston R&D ecosystem in the Global R&D Labs Directory.
Other startups in Houston
- Ally Energy
- AMPeers
- Arriba Foods
- AstroMind
- Atana Elements
- ATAP Market Technologies
- Autoimmunity Biologic Solutions
- Axiom Space
- Biostate AI
- Branch Therapeutics
- Cambrian Network
Related
- Innovation profile of Houston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Bectas Therapeutics do?
Bectas Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Bectas Therapeutics raised?
At least $5.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Bectas Therapeutics based?
Bectas Therapeutics is headquartered in Houston, United States.
When was Bectas Therapeutics founded?
Bectas Therapeutics was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.